Board of Directors

The Kenner Family Research Fund (KFRF), founded in 2013, supports committed activities to develop an early detection protocol for pancreatic cancer. We are more optimistic now than we have ever been about the future of this field. Just as significant progress has been made in the early detection and subsequent treatment for breast, colon, and prostate cancers, we know that advancements are forthcoming for individuals diagnosed with pancreatic cancer. Each year KFRF has expanded its leadership role in creating opportunities for experts in related interprofessional fields to collaborate in strategic innovation and research.

Barbara Kenner, Ph.D., Founder
Nicholas Kenner
Ashley Stark Kenner
Kate Kenner Archibald
Samuel Archibald
Ann Goldberg
Laura Rothschild
Richard Sturmer

Scientific Advisory Board

KFRF is laser-focused on the development of screening methods for pancreatic cancer. Early detection will improve the options for treatment and quality of life for those with pancreatic cancer. Our Scientific Advisory Board members bring their expertise in different aspects of early detection to our conferences.

Suresh T. Chari, M.D., F.A.C.G.
Professor of Medicine
College of Medicine, Mayo Clinic
Consultant, Division of Gastroenterology and Hepatology
Department of Internal Medicine
Mayo Medical Center

Bruce F. Field, P.E.
Principal Engineer
Technology & Advanced Products

Vay Liang W. Go, M.D.
Professor of Medicine,
David Geffen School of Medicine at UCLA
Director, UCLA Center for Excellence in Pancreatic Disease Research
Editor-in-Chief, Pancreas

William Hoos, M.B.A
1440 Foundation,
Chief Commercial Officer of xCures,
Chairman of